Form 8-K - Current report:
SEC Accession No. 0001860782-23-000014
Filing Date
2023-02-06
Accepted
2023-02-06 16:17:03
Documents
12
Period of Report
2023-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20230201.htm   iXBRL 8-K 32724
  Complete submission text file 0001860782-23-000014.txt   173565

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20230201.xsd EX-101.SCH 2008
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20230201_lab.xml EX-101.LAB 24831
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20230201_pre.xml EX-101.PRE 13142
6 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20230201_htm.xml XML 11626
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 23590870
SIC: 2834 Pharmaceutical Preparations